Information on the Target
InvAscent, through India Life Sciences Fund IV (ILSF IV), has made a significant investment of INR 2,300 million in Apex Hospitals Private Limited, a multi-specialty hospital chain specializing in critical care. Headquartered in Jaipur, Rajasthan, Apex Hospitals has developed a strong reputation over the last twenty years for providing quality healthcare services in underserved Tier 2 and Tier 3 cities.
Founded by Dr. S. B. Jhawar, Apex Hospitals operates more than 600 beds across its seven facilities. The hospital chain is known for delivering advanced secondary and tertiary care across various specialties, with a focus on critical care and reliable Intensive Care Unit (ICU) services. Apex has distinguished itself by achieving notable clinical outcomes and pioneering several healthcare innovations in its market.
Industry Overview in Rajasthan
The healthcare industry in India, particularly in Rajasthan, is undergoing rapid transformation, supported by increasing investments and a growing demand for quality care. With a population that relies heavily on regional hospitals, there is a pressing need for more advanced healthcare facilities in Tier 2 and Tier 3 cities. This demand is driven by rising health awareness among consumers and a push by the government to enhance healthcare infrastructure.
Rajasthan has seen a surge in healthcare investments in recent years, facilitating the establishment of various medical facilities to cater to the needs of its residents. The state is focusing on improving healthcare access and affordability, aiming to bridge the gap between urban and rural healthcare services. This creates a conducive environment for hospital chains like Apex Hospitals to expand their reach.
Apex Hospitals positions itself in this evolving landscape by addressing critical care shortages and providing quality medical services at affordable prices. By tapping into local demand and enhancing service delivery, Apex is poised to play a significant role in the healthcare ecosystem in Rajasthan.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The Rationale Behind the Deal
The partnership between InvAscent and Apex Hospitals aims to capitalize on the growing need for critical care facilities across Rajasthan and adjacent regions. The investment serves a dual purpose: it provides a full secondary exit for existing investors while simultaneously infusing primary capital to facilitate further growth. This will allow Apex Hospitals to enhance its infrastructure and expand its geographical footprint.
With the financial backing and strategic expertise of InvAscent, Apex Hospitals can elevate its clinical offerings and scale operations, thereby strengthening its position as a leading healthcare provider. The investment aligns well with both parties' long-term vision of transforming patient care in underserved markets.
Information about the Investor
InvAscent, established in 2005, stands as India’s premier life sciences private equity firm. It manages an asset base exceeding USD 800 million and has vested interests in over 38 companies across various segments, including pharmaceuticals, healthcare delivery, medical devices, and health technology.
The firm's commitment to enhancing patient outcomes through strategic investments in the healthcare sector underscores its role in fostering innovation and expansion. InvAscent’s expertise and resources are focused on identifying sectors that yield significant growth potential, establishing strong partnerships to drive operational improvements.
View of Dealert
In the opinion of deal experts, the investment made by InvAscent in Apex Hospitals represents a strategic move with promising potential. The critical care sector is expanding rapidly, and Apex’s established reputation in this niche positions it favorably for growth. The investment enables Apex to leverage InvAscent’s network and resources to enhance its operational capacities and service offerings.
Furthermore, the focus on affordable healthcare is increasingly relevant, especially in the context of rising health expenses and growing demand for quality services in India. Investors have recognized the opportunity to support healthcare initiatives that not only promise returns but also make a meaningful impact on community health.
Additionally, as Apex expands its services beyond Rajasthan, the partnership with InvAscent could open doors to new markets and patient demographics, further enhancing their growth potential. This strategic collaboration is aligned with the pressing need for improved healthcare services in underserved areas, making it a potentially lucrative and socially beneficial investment.
Similar Deals
TPG Growth, Temasek → Dr Agarwals Health Care Ltd.
2023
360 ONE’s Healthcare Opportunities Fund → A4 Hospitals
2023
India Alternatives → Brinton Pharmaceuticals Ltd
2023
Qatar Investment Authority → Global Dental Services
2023
InvAscent
invested in
Apex Hospitals Private Limited
in 2025
in a Growth Equity deal
Disclosed details
Transaction Size: $28M